Every phosphatidylserine (PS) purchase decision starts with a single number: the PS content on the certificate of analysis, typically 50%, 60%, or 70% for powder grades. Yet that number is only as real as the analytical method behind it — specific to PS, validated for the powder matrix, and executed with documented system suitability. Two suppliers can both print "PS 70%" on their COAs while quantifying different things: one resolving PS from phosphatidic acid and lysophospholipids, the other integrating a cluster of unresolved peaks together. For US and EU buyers this is not academic: the assay number flows into label claims, EU batch-release calculations, and your defense if a customer or regulator challenges the product. This article explains which methods dominate PS quantification, which validation evidence to request, and where the method belongs in commercial negotiation. Buyers preparing this documentation can review our phosphatidylserine programme alongside the grade, source and market detail above.
Why the Assay Method Decides What a PS Specification Is Worth
Phosphatidylserine is not one molecule but a class: the same serine headgroup on diacylglycerol backbones carrying different fatty acid chains. A PS powder also contains related species — phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidic acid (PA), phosphatidylinositol (PI), and lysophospholipids — all structurally similar and all responding similarly in most detectors. Quantifying PS therefore means chromatographically separating it from its nearest relatives.
Methods that fail at this separation overstate or understate PS content depending on how the analyst integrates the region. A "total phosphorus" colorimetric approach measures all phospholipids and cannot distinguish PS from PC at all. Reversed-phase HPLC with evaporative detectors can resolve individual classes when the gradient and column are appropriate; LC-MS resolves them unambiguously. The practical consequence: two COAs at "70%" may describe powders differing by 3–6 percentage points of true PS class content — and your finished-product label claim inherits whatever bias the ingredient method carries.
The Method Landscape: HPLC-CAD, HPLC-ELSD, LC-MS, and Legacy Alternatives
Four method families matter in today's PS trade:
HPLC with charged aerosol detection (CAD). Increasingly the default for phospholipid quantification. CAD responds nearly mass-proportionally to nonvolatile analytes, suiting phospholipids that lack chromophores, with a wide dynamic range; PS elutes as a discrete peak family separated from PC, PE, and PA.
HPLC with evaporative light-scattering detection (ELSD). The workhorse of the previous decade, still widely used in Asia-based manufacturing. Valid ELSD methods perform well, but response is more compound- and condition-dependent, so calibration standard choice (ideally a PS reference material) and gradient reproducibility matter more.
LC-MS / 31P NMR. Orthogonal, higher-cost techniques for identity confirmation and dispute resolution. 31P NMR distinguishes phospholipid classes by phosphorus chemical shift and verifies the claimed class distribution. Most buyers will not run these routinely but should name them as referee methods in quality agreements.
Legacy colorimetric/phosphorus methods. Acceptable only as rough process controls, not as release methods for a specification that claims PS class content.
When qualifying a supplier, ask which family the release method belongs to, and require the method summary — column, mobile phases, gradient, detector, calibration standard, and system suitability criteria — as a controlled document referenced by the specification.
Validation Parameters a Buyer Should Ask to See
A method is only credible when validated for the specific matrix. Reference ICH Q2(R2), the benchmark US and EU quality teams recognize, alongside 21 CFR Part 111 obligations for US dietary supplement manufacturers (§111.320 requires scientifically valid testing). For a PS powder assay, request evidence covering:
- Specificity: chromatograms showing baseline separation of the PS peak from PC, PE, PA, PI, and lysophospholipids in a representative powder, not just a neat standard — ask for the resolution value against the nearest adjacent peak.
- Linearity and range: response across the range bracketing the specification, with the calibration model stated. Evaporative detectors often require nonlinear (log-log or quadratic) fits — a hidden source of inter-lab bias.
- Accuracy: recovery experiments, typically spiked at several levels or assessed against a reference material.
- Precision: repeatability and intermediate precision (different day, analyst, or instrument); for an assay near 70%, repeatability RSDs of a couple of percent or better are reasonable.
- Detection and quantification limits (LOD/LOQ): more relevant to minor phospholipid species than to the main PS assay, but expected in the dossier.
- Robustness: deliberate small variations in gradient, flow, and temperature showing the method tolerates routine laboratory drift.
You do not need to re-verify every parameter yourself; you need the documents to exist, reference recognized frameworks, and survive a read-through by an auditor.
Audit Points: What to Request from the Supplier and the Lab
During supplier qualification or an on-site (or remote) audit, walk the assay end to end:
- Method identification on the COA. Each COA line should trace to a documented, version-controlled method. "HPLC" with no method code is a red flag.
- System suitability records. Before each sequence the lab should inject a standard confirming resolution, tailing, and response criteria, with records reviewable.
- Calibration standard provenance. What PS reference is used, from which vendor, at what documented purity? A cheap mixed-lecithin "standard" is the most common shortcut.
- Raw chromatograms on request. Suppliers confident in their methods provide annotated chromatograms of the lot in question; hesitation suggests unresolved peaks.
- Analyst competence and equipment maintenance for in-house labs, or a qualified third-party lab with scope documents covering phospholipid analysis.
- Change control on the method. Any column or detector change should route through the change-notification terms in your quality agreement.
Incoming Testing Alignment and the Cost of Method Mismatch
The most expensive version of a method problem is the one discovered after the container has landed. If your incoming test uses a CAD method and the supplier's release used ELSD with different integration conventions, you will periodically see 2–4 point assay gaps on identical powder — each triggering investigation, quarantine, and production rescheduling.
Prevent this structurally. During qualification, send one well-characterized retained lot to the supplier's lab and to a neutral third-party lab, compare results, and document the acceptable difference. If the bias is systematic, either align on one method or build it into the specification limits knowingly. Frame the outcome in your quality agreement as an agreed method hierarchy: supplier release method for release, named third-party laboratory and referee method (for example LC-MS or 31P NMR) for disputes.
Budget note: a contract laboratory per-sample PS assay by HPLC typically runs in the low hundreds of US dollars — trivial against the landed value of a pallet, and cheap insurance against releasing mislabeled material into capsules, gummies, or RTD beverages where the error becomes your product's error.
Negotiation Levers for US/EU Contracts
The assay method belongs in commercial terms, not only technical annexes:
- Specification reference: the purchase order's specification exhibit should name the release method by code and version, with changes requiring advance notification under the change-control clause.
- Referee method clause: name the dispute method and the neutral laboratory before a dispute exists; the party whose result deviates bears retesting costs.
- Retest and retain samples: align with your reserve-sample expectations so a challenged assay can be re-examined from retained material, not from drums already consumed.
- Method transition protection: when a supplier migrates from ELSD to CAD mid-relationship, require bridging data on three lots so historical scorecard comparability is preserved.
These clauses cost suppliers little if their methods are sound — which is precisely what makes them useful qualification screens.
FAQ
Q: Does the supplier need full ICH Q2 validation, or is verification enough?
A: For a compendial or platform method applied unchanged, a documented verification against ICH Q2(R2) principles may be adequate; for a method developed in-house for a specific PS matrix, expect full validation with the parameters above. Either way, the defining test is whether the lab can produce the report on request within days.
Q: Can I rely on the COA and skip incoming assay testing?
A: US dietary supplement GMPs under 21 CFR Part 111 generally require you to establish, by testing or by supplier verification, that specifications are met — a COA alone is acceptable only where its reliability is verified. Many buyers use periodic or skip-lot confirmatory testing, with frequency risk-based on the supplier's history.
Q: What PS assay value should a 50% or 70% grade actually deliver?
A: Judge against the specification basis (as-is versus anhydrous or solvent-free), not a single number. A "70% PS" powder assaying 69.2% as-is within documented analytical uncertainty is compliant; the same powder presented on an anhydrous basis when moisture is 2% is not. Confirm the basis is identical on specification, COA, and label-calculation sheet.
Q: The supplier's COA says 72% but my lab reports 68%. Who is right?
A: Neither yet. First check method identity, basis, and integration conventions, then trigger the referee method named in your quality agreement — LC-MS or 31P NMR resolves most discrepancies. If the gap is systematic and method-driven, fix the method hierarchy contractually rather than litigating individual lots.
Q: Are spectroscopic "total phospholipid" methods acceptable for identity?
A: They can support identity confirmation as a complementary test, but they cannot quantify the PS class specifically. Keep them off the release specification for PS content, or cap their role at screening.
Conclusion
A phosphatidylserine specification is a promise about a chromatogram. Buyers who treat "% PS" as method-neutral absorb label-claim risk, incoming-test disputes, and audit findings that were preventable at qualification time. Ask which method family the supplier uses, request ICH Q2-aligned validation evidence for the matrix, verify system suitability and calibration provenance during audits, align methods across supplier and incoming labs before the first order, and write the method hierarchy — referee method and cost allocation included — into the quality agreement. None of this adds cost to a sound supplier; all of it exposes a fragile one early. When you are ready to move from checklist to quotation, contact our team with the grade, source and document set described above.
Sources
- ICH — Q2(R2) Validation of Analytical Procedures (harmonized guideline): https://www.ich.org/page/quality-guidelines
- FDA — 21 CFR Part 111, Current Good Manufacturing Practice for Dietary Supplements (testing and scientific validity, §111.320): https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
- FDA — Laboratory Methods for Food (analytical methods used in FDA programs): https://www.fda.gov/food/laboratory-methods-food
- PubMed (NIH/NLM) — peer-reviewed literature on phosphatidylserine quantification by HPLC and LC-MS: https://pubmed.ncbi.nlm.nih.gov/?term=phosphatidylserine+HPLC+quantification
- USP — Dietary Supplements compendial standards and reference materials: https://www.usp.org/dietary-supplements
Buyer fit
Who this guide is for
This guide is written for the buyer profiles below. Open your profile for the matching grades, documents and next steps, or tell us your requirements directly.
Recommended next steps
- Review the Phosphatidylserine product page.
- Compare Soy PS and Sunflower PS.
- Check manufacturing proof and Quality & R&D.
Contact sales for product documents
Share source preference, application, country, and annual quantity.
Contact Sales
